Benzinga's Top Upgrades By: Benzinga via Benzinga May 06, 2014 at 07:57 AM EDT Analysts at Bank of America upgraded Seattle Genetics (NASDAQ: SGEN) from “underperform” to “neutral.” The target price for Seattle ... Read More >> Related Stocks: Charles Schwab Seagen Inc